medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2023, Number 2

<< Back Next >>

Rev Med UAS 2023; 13 (2)

Spectral Doppler evaluation as part of the study of suspicious breast nodules and its correlation with the histopathological study

Loza-Ramírez EA, Guerrero-Amador FI, Zatarain-Bayliss L

Language: Spanish
References: 33
Page: 217-230
PDF size: 468.66 Kb.


ABSTRACT

Breast cancer is a complex natural history disease that continues to be a major public health problem worldwide. Mammography is the screening method for the early detection of breast cancer that has proven most useful and that helps reduce mortality, however, breast ultrasound is a valuable complementary diagnostic tool, which helps to perform a better analysis of the breast lesions and incorporating tools such as Doppler or elastography. The examination with Doppler ultrasound shows the degree of vascularity of the lesion, as well as the different comportments of the vessels, which helps to make a greater approximation to determine if a lesion exhibit benign or malignant characteristic. The Resistance index is a spectral Doppler parameter that has shown an increase in ma-lignant lesions.


REFERENCES

  1. Cárdenas SJ, Erazo VA, Arce SC, Bargallo E, Baustista PV, Cervantes SG, et. al. Con-senso Mexicano Ca Mama, Colima. Gaceta Mexicana de Oncología. 2019, 8va edición. 18. 141.

  2. Huicochea CS, González BP, Tovar CIL, Olarte CMA, Vázquez LJ. Cáncer de mama. An Radiol Méx 2009;8(1):117-126.

  3. NORMA Oficial Mexicana NOM-041-SSA2-2011, Para la prevención, diagnóstico, tra-tamiento, control y vigilancia epidemiológica del cáncer de mama.

  4. Torres RH, Silva LLM, Tenorio FE, Ríos RN. Correlación histopatológica de hallazgos ra-diológicos BI-RADS 4, 5 y 6. An Radiol Méx 2012;11(2):114-120.

  5. Torres TM. Novedades de la 5.a edición del sistema breast imaging reporting and data system (BI-RADS®) del Colegio Americano de Radiología. Rev Senol Patol Mamar. 2016;29(1):32-39

  6. Lehman CD, Lee CI, Loving VA, Portillo MS, Peacock S, DeMartini WB. Accuracy and value of breast ultrasound for primary ima-ging evaluation of symptomatic women 30-39 years of age. AJR Am J Roentgenol. 2012;199(5):1169-1177.

  7. Concepción QL, Rodríguez DY, Campos VO. Caracterización de las lesiones no pal-pables de la mama. Rev Haban Cienc Med. 2015;14(6):747-759.

  8. Leddy R, Irshad A, Zerwas E, Mayes N, Ar-meson K, Abid M, et al. Role of breast ul-trasound and mammography in evaluating patients presenting with focal breast pain in the absence of a palpable lump. Breast J. 2013;19(6):582-589.

  9. Dobrosavljević A, Rakić S, Nikolić B, Janko-vić-Ražnatović S, Dragojević-Dikić S, Mi-lošević Z, et al. Diagnostic value of breast ultrasound in mammography BI-RADS 0and clinically indeterminate or suspicious of malignancy breast lesions. Vojnosanit Pregl. 2016;73(3):239-245.

  10. Villa H, Pabón J, Jaramillo N, Mantilla J. Ul-trasonografía de mama. MedUNAB. 2006;9(2):98-107.

  11. Atencia BM, Díaz CG, Pardo SE, Garrido RG, Moreno MS, Irigoyen OJ. Cómo elabo-rar el informe de ecografía de mama. Des-criptores ecográficos del BI-RADS. 32 Con-greso Nacional de la SERAM; 2014 Mayo 22-25; Oviedo, España. SERAM 2014,1-25.

  12. Díaz H, Huerto I. Rol actual de la ecografía en el diagnóstico del cáncer de mama. Rev Per Ginecol Obstet. 2007;53(1):52-60.

  13. Guío JI, García ÓA, Buitrago ML. Frecuen-cia de cáncer en pacientes con ecografía mamaria BI-RADS 4A. Repert Med Cir. 2015;24(3):219-225.

  14. García-Quintanilla JF, González CSI, Gas-cón MA, Hernández BL, Barrera LF, Lavín AR. Lesiones BIRADS 3 y 4 vistas por ultra-sonido y no vistas por mamografía digital y tomosíntesis. AN Radiol Méx. 2016;15(3):205-213.

  15. Cisneros L, Mendoza H, Ríos NN, Guerrero AG. Seguimiento mamográfico, ecográfico y su correlación histopatológica en lesiones categorizadas con BI-RADS 3, 4 y 5. An Ra-diol Méx 2009;8(2):151-155.

  16. Elverici E, Barça AN, Aktaş H, Özsoy A, Zengin B, Çavuşoğlu M, et al. Nonpalpable BI-RADS 4 breast lesions: sonographic fin-dings and pathology correlation. Diagn In-terv Radiol. 2015;21(3):189-194.

  17. Horvath E, Cuitiño MJ, Pinochet MÁ, San-hueza P. Doppler color en el estudio de la mama: ¿Cómo lo hacemos nosotros? Rev Chil Radiol. 2011;17(1):19-27.

  18. Gupta K, Chandra T, Kumaresan M, Venka-tesan B, Patil AB. Role of Colour Doppler in Assessment of Malignancy in Solid Breast Masses: A Prospective Study. J Anat Radiol Cirug. 2017;6(1):59-65.

  19. Ibrahim R, Rahmat K, Fadzli F, Rozalli FI, Westerhout CJ, Alli K, et al. Evaluation of solid breast lesions with power Doppler: va-lue of penetrating vessels as a predictor of malignancy. Singapore Med J. 2016;57(11):634-640.

  20. Peters-Engl C, Medl M, Leodolter S. The use of colour-coded and spectral Doppler ultrasound in the differentiation of benign and malignant breast lesions. Br J Cancer. 1995;71(1):137

  21. Tozaki M, Fukuma E. Does power Doppler ultrasonography improve the BI-RADS cate-gory assessment and diagnostic accuracy of solid breast lesions? Acta Radiol. 2011;52(7):706-710.

  22. Stanzani D, Chala LF, Barros N, Cerri GG, Chammas MC. Can Doppler or contrast-en-hanced ultrasound analysis add diagnosti-cally important information about the nature of breast lesions? Clinics. 2014;69(2):87-92.

  23. Joseph VD, Varghese AE, TGA. Analyzing the Role of Spectral Indices in Differentia-ting Benign and Malignant Breast Lesions. J Med Sci Clin. res. 2017;5(7):25404-25408.

  24. Peters-Engl C, Medl M, Mirau M, Wanner C, Bilgi S, Sevelda P, et al. Color-coded and spectral Doppler flow in breast carcinomas-relationship with the tumor microvascula-ture. Breast Cancer Res Treat. 1998;47(1):83-89.

  25. Shaheen R, Sohail S, Siddiqui KJ. Neovas-cularity patterns in breast carcinoma: corre-lation of Doppler ultrasound features with sonographic tumour morphology. J Coll Physicians Surg Pak. 2010;20(3):162-166.

  26. Gokalp G, Topal U, Kizilkaya E. Power Do-ppler sonography: Anything to add to BI-RADS US in solid breast masses? Eur J Ra-diol, 2009;70(1):77-85.

  27. Choi HY, Kim HY, Baek SY, Kang BC, Lee SW. Significance of resistive index in color Doppler ultrasonogram: differentiation bet-ween benign and malignant breast masses. Clin Imaging. 1999;23(5):284-288

  28. Hayashi N, Miyamoto Y, Nakata N, Irie T, Ikegami M, Asao K, et al. Breast masses: Color Doppler, power Doppler, and spectral analysis findings. J. Clin. Ultrasound. 1998;26(5):231-238.

  29. Alikhassi A, Zamani Nokandeh S, Mousavi K, Saffar H, Gity M, Ahmadinejad N. Can Color and Spectral Doppler Ultrasound of Breast Cancers Help to Predict the Im-munohistochemistry profile? Arch Breast Cancer. 2019;6(4):161-167.

  30. Ara S, Jesmin S, Sattar A, Akhter S, Jahan W, Kabir A, et al. Validity of Gray Scale So-nography along with Color Doppler Spectral Analysis for the detection of Malignant Breast Tumour. Bangla JOL. 2017;3(1):10-13.

  31. Keshavarz E, Zare MM, Karimi MA, Valian N, Kalantari M, et al. Diagnostic Value of Spectral Doppler Ultrasound in Detecting Breast Malignancies: An Original Article, Int J Cancer Manag. 2018;11(2):e8200

  32. Tozaki M, Toi M, Miyamoto Y, Fukuda K. Power Doppler sonography of breast mas-ses: correlation of Doppler spectral parame-ters with tumor angiogenesis and histologic growth pattern. J Ultrasound Med. 2000;19(9):593-600.

  33. Davoudi Y, Borhani B, Rad M, Matin N. The Role of Doppler Sonography in Distinguis-hing Malignant from Benign Breast Lesions. J Med Ultrasound. 2014;22(2):92-95.




2020     |     www.medigraphic.com